Database of patients with chronic lymphatic leukemia
Official title: Institut Paoli Calmettes Chronic Lymphatic Leukemia Database
Run by Institut Paoli-Calmettes · NCT02869529 · Data updated 2026-11-12
This study is collecting information from patients with chronic lymphatic leukemia to help researchers understand the disease better and improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 95 Years |
| Sex | All |
| Enrollment | 4200 (estimated) |
| Sponsor | Institut Paoli-Calmettes Academic / other |
| Locations | 1 site (Marseille, Bouches-du Rhône) |
| Status | Recruiting |
| Started | January 2006 |
| Main results expected | January 2030 |
| Study ends | December 2030 |
| Registry record updated | August 17, 2016 |
| Trial ID | NCT02869529 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with chronic lymphatic leukemia.
✕Probably not a fit
Patients with a Matutes score of less than 4 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves the collection of data from patients diagnosed with chronic lymphatic leukemia at the Institut Paoli-Calmettes. The observational approach allows for the gathering of comprehensive clinical information to better understand the disease and its progression. By compiling this database, researchers aim to facilitate future studies and improve patient care through enhanced knowledge of chronic lymphatic leukemia.
Why it matters
Potential benefit: If successful, this database could lead to improved treatment strategies and outcomes for patients with chronic lymphatic leukemia.
How similar studies have gone: Other studies utilizing patient databases for chronic lymphatic leukemia have shown promise in advancing understanding and treatment of the disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of chronic lymphatic leukemia Exclusion Criteria: * Score of Matutes \<4
Where it's running
-
Institut Paoli-Calmettes
Marseille, Bouches-du Rhône, France Recruiting
Study contacts
- Study coordinator: Dominique Genre, MD
- Email: drci.up@ipc.unicancer.fr
- Phone: 0033491223778
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ibrutinib and Venetoclax for Chronic Lymphocytic Leukemia in Real-World Care
This study tests whether a fixed-duration Ibrutinib plus Venetoclax treatment works in real-world care for people with CLL or SLL.
-
Treatment for Chronic Lymphocytic Leukemia using modified T cells
This study is testing a new treatment using modified T cells to see if it can help people with chronic lymphocytic leukemia that hasn't responded to other therapies.
-
Impact of physical activity on quality of life for patients with chronic lymphocytic leukemia
This study is testing if adding physical activity to the routine of patients with chronic lymphocytic leukemia starting ibrutinib treatment can improve their quality of life.
-
Comparing two treatments for relapsed chronic lymphocytic leukemia
This study is testing if a new combination of two drugs, nemtabrutinib and venetoclax, can help people with relapsed chronic lymphocytic leukemia live longer without their cancer getting worse compared to the usual treatment.
-
Study of family connections in blood and lymph cancers
This study looks at families with multiple members diagnosed with blood and lymph cancers to see if genetics and environmental factors play a role in their development.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.